Eurozone Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France’s Healthcare Sector – AstraZeneca (NASDAQ:AZN), Pfizer (NYSE:PFE), Sanofi (NASDAQ:SNY) Read more
Biotechnology Brexit Impact On Drugs – Rising Shortages in UK Highlight Brexit Challenges – AstraZeneca (NASDAQ:AZN), Johnson & Johnson (NYSE:JNJ), GSK (NYSE:GSK) Read more
Biotechnology Amgen/AstraZeneca’s Asthma Drug Tezspire Vs. Sanofi/Regeneron’s Blockbuster Dupixent – Analyst Gives His Pick – AstraZeneca (NASDAQ:AZN), Amgen (NASDAQ:AMGN) Read more
Biotechnology AstraZeneca’s Imfinzi/Chemo Combo Doubles Overall Survival In Biliary Tract Cancer Patients At 3 Years, Data Shows – AstraZeneca (NASDAQ:AZN) Read more
Opinion Biotech Innovations Paving the Way in Breast Cancer Fight – AstraZeneca (NASDAQ:AZN), Gilead Sciences (NASDAQ:GILD) Read more
Biotechnology AstraZeneca/Daiichi’s Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor – AstraZeneca (NASDAQ:AZN) Read more
Biotechnology New Hope for Aggressive Lung Cancer: AstraZeneca’s Imfinzi Shows Promising Results in Phase 3 Trial – AstraZeneca (NASDAQ:AZN) Read more
Biotechnology What’s Going With AstraZeneca Stock Trading Higher Today? – AstraZeneca (NASDAQ:AZN) Read more
Biotechnology After Failed Prostate Cancer Study Merck’s Keytruda Combination Therapy Flunks In Late-Stage Lung Cancer Study – Merck & Co (NYSE:MRK) Read more
